ZBED3
ZBED3 (zinc finger BED-type containing 3, also known as MGC15435) is a regulatory protein that positively regulates canonical Wnt/beta-catenin signalling by stabilising cytoplasmic beta-catenin. It also contributes to early embryonic cell division. Browse Assay Genie's current range of ZBED3 research reagents below, or read on for the biology behind the target.
ZBED3 acts as a positive regulator of the canonical Wnt/beta-catenin signalling pathway. It does so by stabilising cytoplasmic beta-catenin, and it is also involved in activating the transcription of Wnt target genes. Beyond signalling, ZBED3 plays a role in the symmetric division of blastomeres in the early stages of embryogenesis, through regulation of central positioning of the mitotic spindle and organisation of the F-actin filament network.
The ZBED3 gene belongs to the HGNC groups of BED-type zinc fingers and of small nucleolar RNA protein coding host genes. According to the NCBI Gene summary, it belongs to a class of genes that arose through hAT DNA transposition and that encode regulatory proteins. UniProt records the ZBED3 protein, zinc finger BED domain-containing protein 3, in the cytoplasm, at the membrane and as a secreted protein. The mouse ortholog is Zbed3.
ZBED3 has been linked to disease in the RefSeq summary. The gene is upregulated in lung cancer tissues, where the encoded protein causes an accumulation of beta-catenin and enhances lung cancer cell invasion. The protein can also be secreted and has been implicated in resistance to insulin. These findings make the ZBED3 gene and its product relevant to studies of Wnt signalling, tumour cell behaviour and metabolic regulation.
ZBED3 stabilises cytoplasmic beta-catenin and promotes Wnt target gene transcription, making it a useful node for studying canonical Wnt pathway activation.
ZBED3 is upregulated in lung cancer tissues, where it causes beta-catenin accumulation and enhances cancer cell invasion.
ZBED3 contributes to symmetric blastomere division by regulating mitotic spindle positioning and the F-actin filament network.
The secreted form of ZBED3 has been implicated in resistance to insulin, pointing to a role in metabolic research.
ZBED3 is a positive regulator of canonical Wnt/beta-catenin signalling. It stabilises cytoplasmic beta-catenin and is involved in activating Wnt target gene expression. It also helps regulate mitotic spindle positioning and the F-actin network during symmetric blastomere division in early embryogenesis.
The HGNC-approved name is zinc finger BED-type containing 3, and UniProt calls the protein zinc finger BED domain-containing protein 3. The alias MGC15435 is also recorded. HGNC lists no previous names. The gene is grouped with BED-type zinc fingers and small nucleolar RNA protein coding host genes.
ZBED3 is upregulated in lung cancer tissues, where it drives beta-catenin accumulation and cancer cell invasion, and the secreted protein has been implicated in insulin resistance. A mouse ortholog, Zbed3, exists. Check the datasheet of any product for its validated reactivity.
Beta-catenin, Wnt pathway components and other regulators of Wnt signalling with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q96IU2; product specifications from Assay Genie datasheets.